New York, NY, United States of America

Olivier F Danos

This inventor holds 7 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Meiragtx UK Ii Limited, Meiragtx Gene Regulation Limited. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olivier F Danos. Retrieved from https://idiyas.com/inventor/olivier-f-danos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • New York, NY (US) (2019 - 2022)
  • Boston, MA (US) (2023)

Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Olivier F Danos: Innovator in Gene Regulation

Introduction

Olivier F Danos is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of gene regulation, holding a total of 7 patents. His work focuses on innovative methods for controlling gene expression, which have important implications in biotechnology and medicine.

Latest Patents

Danos's latest patents include groundbreaking inventions such as "Regulation of gene expression by aptamer-mediated modulation of alternative splicing." This invention provides a platform and methods for regulating the expression of a target gene using exposure to an aptamer ligand. The platform features a polynucleotide gene regulation cassette that is integrated into the target gene, including a synthetic riboswitch that controls splicing based on the presence of a ligand. When the ligand is absent, the alternative exon is spliced into the target gene mRNA, preventing expression. Conversely, when the ligand is present, the alternative exon is excluded, allowing for gene expression.

Another notable patent is "Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymes." This invention offers polynucleotide constructs that modulate gene expression through aptamer-based regulation of self-cleaving ribozymes. The methods described allow for the control of gene expression in response to ligand binding, providing a versatile tool for genetic engineering.

Career Highlights

Throughout his career, Olivier F Danos has worked with various companies, including MeiraGTx UK Limited and MeiraGTx Gene Regulation Limited. His expertise in gene regulation has positioned him as a key figure in the biotechnology sector, contributing to advancements in therapeutic applications.

Collaborations

Danos has collaborated with notable professionals in his field, including Michael J Volles and Xuecui Guo. These collaborations have further enhanced his research and development efforts in gene regulation technologies.

Conclusion

Olivier F Danos is a distinguished inventor whose work in gene regulation has led to significant advancements in biotechnology. His innovative patents and collaborations reflect his commitment to enhancing our understanding and control of gene expression.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…